Frankfurt - Delayed Quote EUR

Galapagos NV (GXE.F)

24.34
-0.12
(-0.49%)
At close: June 6 at 9:38:12 PM GMT+2
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
288,194
275,649
239,724
241,249
234,384
Cost of Revenue
46,044
34,863
0
0
1,629
Gross Profit
242,150
240,786
239,724
241,249
483,217
Operating Expense
556,065
429,124
327,987
372,306
405,949
Operating Income
-313,915
-188,338
-88,263
-131,057
-171,565
Net Non Operating Interest Income Expense
75,789
89,458
77,636
8,709
-9,296
Other Income Expense
55,782
95,795
16,252
51,499
61,462
Pretax Income
-182,387
-3,085
5,625
-70,849
-119,402
Tax Provision
-3,049
-1,803
9,613
572
1,389
Net Income Common Stockholders
-169,541
74,082
211,697
-217,991
-103,231
Diluted NI Available to Com Stockholders
-169,541
74,082
211,697
-217,991
-103,231
Basic EPS
-2.58
1.12
3.21
-3.32
-1.58
Diluted EPS
-2.58
1.12
3.21
-3.32
-1.58
Basic Average Shares
65,893.05
66,144.64
65,884
65,659.94
65,500
Diluted Average Shares
65,893.05
66,144.64
65,884
65,659.94
65,500
Total Operating Income as Reported
-313,915
-188,338
-88,263
-131,056
-171,568
Total Expenses
602,109
463,987
327,987
372,306
405,949
Net Income from Continuing & Discontinued Operation
-169,541
74,082
211,697
-217,991
-103,231
Normalized Income
-234,187.48
-76,960.05
-16,827.08
-112,105.21
-165,658.26
Interest Income
76,630
89,773
79,608
18,094
2,865
Interest Expense
--
911
1,770
9,155
11,592
Net Interest Income
75,789
89,458
77,636
8,709
-9,296
EBIT
-127,751
-2,174
7,395
-61,694
-107,810
EBITDA
-127,751
43,325
51,037
3,872
-73,174
Reconciled Cost of Revenue
46,044
2,536
0
0
1,629
Reconciled Depreciation
--
45,499
43,642
65,566
34,636
Net Income from Continuing Operation Net Minority Interest
-179,338
-1,282
-3,988
-71,421
-120,791
Total Unusual Items Excluding Goodwill
55,782
95,795
16,252
51,499
61,462
Total Unusual Items
55,782
95,795
16,252
51,499
61,462
Normalized EBITDA
-183,533
-52,470
34,785
-47,627
-134,636
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
932.52
20,116.95
3,412.92
10,814.79
16,594.74
12/31/2021 - 6/28/2005

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

IMR.BE AC Immune SA
1.7820
+18.80%
 
ABRT.CN Albert Labs International Corp.
0.0050
0.00%
 
2H51.F Ocugen, Inc.
0.9198
+8.60%
 
8EM.BE Editas Medicine Inc
1.5245
-1.33%
 
2LB.MU Iovance Biotherapeutics Inc
1.5644
0.00%
 
5CV.HA CureVac NV
3.8120
-0.78%
 
GYX.F Futura Medical plc
0.0895
-0.56%
 
BT1.BE Bone Therapeutics SA
0.0018
0.00%
 
0M4.F Mersana Therapeutics, Inc.
0.2900
+8.78%
 
2LB.F Iovance Biotherapeutics, Inc.
1.5496
-4.11%